These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31821788)

  • 21. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Reactions after Administration of Antivenom in Korea.
    Shim JS; Kang H; Cho Y; Shin H; Lee H
    Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32781766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Black Mamba Death: Venom Versus Antivenom?
    Blumenthal R; Scholtz PEP; Shuttleworth JL
    Am J Forensic Med Pathol; 2019 Dec; 40(4):356-360. PubMed ID: 31318708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight cases of acute renal failure from Vipera russelli formosensis venom after administration of antivenom.
    Chou TS; Lin TJ; Kuo MC; Mee-Sun T; Hung DZ; Tsai JL
    Vet Hum Toxicol; 2002 Oct; 44(5):278-82. PubMed ID: 12361111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
    Alirol E; Sharma SK; Ghimire A; Poncet A; Combescure C; Thapa C; Paudel VP; Adhikary K; Taylor WR; Warrell D; Kuch U; Chappuis F
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005612. PubMed ID: 28510574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snake venom or antivenom induced urticaria.
    Keyler DE; Steinberg P
    Vet Hum Toxicol; 1991 Jun; 33(3):283-4. PubMed ID: 1858314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Snake antivenom.
    Sakai A
    Chudoku Kenkyu; 2017 Mar; 30(1):41-45. PubMed ID: 30549927
    [No Abstract]   [Full Text] [Related]  

  • 30. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18).
    Isbister GK; Buckley NA; Page CB; Scorgie FE; Lincz LF; Seldon M; Brown SG;
    J Thromb Haemost; 2013 Jul; 11(7):1310-8. PubMed ID: 23565941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13).
    Isbister GK; O'Leary MA; Elliott M; Brown SG
    Med J Aust; 2012 Aug; 197(3):173-7. PubMed ID: 22860796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 34. Antivenom therapy for crotaline snakebites: has the poison control center provided effective guidelines?
    Chen YC; Chen MH; Wang LM; Wu JJ; Huang CI; Lee CH; Yen DH; Yang CC
    J Formos Med Assoc; 2007 Dec; 106(12):1057-62. PubMed ID: 18194914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms.
    León G; Herrera M; Segura Á; Villalta M; Vargas M; Gutiérrez JM
    Toxicon; 2013 Dec; 76():63-76. PubMed ID: 24055551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of adverse effects in the use of powder trivalent antivenom and liquid antivenoms in Bothrops snake bites.
    da Silva IM; Tavares AM
    Rev Soc Bras Med Trop; 2012; 45(4):523-5. PubMed ID: 22930051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snake bites recorded by veterinary practices in Australia.
    Mirtschin PJ; Masci P; Paton DC; Kuchel T
    Aust Vet J; 1998 Mar; 76(3):195-8. PubMed ID: 9578756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
    Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
    Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivenom efficacy, safety and availability: measuring smoke.
    Cheng AC; Winkel KD
    Med J Aust; 2004 Jan; 180(1):5-6. PubMed ID: 14709119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
    Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
    Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.